image title

Nancy Gonzales named ASU's next university provost, executive VP

New university provost and ASU alum was 1st in her family to get college degree.
December 1, 2020

Dean of natural sciences' career dedicated to psychology research with culturally diverse populations, expanding access to education

Editor’s note: This story is being highlighted in ASU Now’s year in review. Read more top stories from 2020.

When Nancy Gonzales graduated high school in Miami, Arizona, she was awarded an Arizona Board of Regents scholarship, which at the time was given to the top 1% of students in the state to attend any of the three state universities. There was never really any question that she would choose Arizona State University.

“My father was a huge Sun Devil supporter and football season ticket holder for as long as I can remember. This created a strong connection to the university that influenced my decision to attend ASU and become the first in my family to earn a college degree,” she said.

That decision launched a 25-year award-winning career in psychology with a focus on research and outreach to communities often underrepresented in higher education in the United States. Today, Gonzales is being named ASU’s next executive vice president and university provost.  

“As an undergraduate student at ASU I became engaged with outstanding, forward-thinking faculty members and research teams pursuing big ideas in the psychology department that were early exemplars of ASU’s community-embedded, use-inspired research,” said Gonzales. “Since I returned to ASU, it has been exciting to participate in the bold transformation of ASU as the New American University and to see our mission expand beyond anything we had imagined before.”  

Her appointment is subject to approval by the Arizona Board of Regents. She will serve as provost pro tem and work with current Executive Vice President and University Provost Mark Searle until June 30, 2021, when he steps down and moves into the role of University Professor. Gonzales will start her official term as executive vice president and university provost on July 1.

Gonzales will be responsible for the Academic Enterprise of ASU and will lead a complex organization that provides a multitude of opportunities and challenges to ensure the university continues progress toward its charter and goals. She will engage in all aspects of the day-to-day operations of the university as well as developing and supporting long-term strategic initiatives to drive student and faculty success. Her duties also will include advancing academic excellence through the faculty recruitment, retention and renewal processes, and growing the quality, scope and scale of both campus immersion and online programs.

“Nancy is a highly credentialed, well-respected leader among her peers who is a natural fit to be our next executive vice president and university provost,” said ASU President Michael M. Crow. “As a first-generation college graduate, she is representative of so many of the students we currently serve and strive to serve more of. Her background and expertise will undoubtedly help the university advance its mission to be of the greatest public service to the citizens of Arizona that we can be.”

Gonzales said she considers herself the product of the right combination of opportunities, stemming from a strong family and a community with a focus on maintaining cultural strengths and being afforded a quality education despite limited financial resources.

“Part of what I hope to do is provide those conditions for success to more students ,” she said. “I don’t think it’s a big mystery as to what individuals need to thrive in life. But we need to find flexible ways to provide those opportunities for more of our students, and at times in life when they can benefit most. I am inspired by ASU’s charter that prioritizes access and inclusion, and our commitment to universal learning as a means to achieving these goals.”

Gonzales received a bachelor’s degree in psychology from ASU, then left Arizona to pursue her master’s degree and PhD in psychology from the University of Washington. She also completed an internship in clinical psychology at the Stanford University School of Medicine. She came back to ASU in 1992 as an assistant professor in psychology and moved up through both the academic and administrative ranks, most recently serving as dean of natural sciences in The College of Liberal Arts and Sciences. She is also a Foundation Professor of psychology and co-director of the REACH Institute at ASU.

While at the University of Washington, she found a mentor in Ana Mari Cauce, then a professor of psychology and now president of the university. Cauce also served as provost and executive vice president.

Cauce’s focus on diverse populations — she is trained in community psychology focused on community change — was what Gonzales wanted to pursue in her career.

“I gravitated to Ana Mari because of her approach to research and her focus on underrepresented populations,” Gonzales said. “Thirty years ago, our knowledge of psychology was derived almost entirely from white middle-class populations.  In fact, too much of our research in psychology has been based on WEIRD populations — Western, educated, industrialized, rich and democratic — that ultimately limits our understanding of the human condition and ultimately leads to damaging assumptions and social policies.” 

Cauce said she can’t think of anyone better suited for this position at ASU — an excellent public research university that is so dedicated to, and successful at, increasing access to higher education for all.

“Her own journey is proof positive of the transformative power of higher education,” said Cauce. “The depth of her intelligence, curiosity, creativity and compassion, as well as sheer grit and determination, was evident from the moment we met. Serious, but with a wonderful sense of humor, she very quickly became a leader in the lab, dedicated to bringing out the best in others. She has an uncanny ability to read people and situations and adapt her leadership style accordingly. ASU and all of higher education will be better off with her in this position. I have no doubt that her impact will be broad and lasting.”

Gonzales has been active in developmental and clinical research with culturally diverse populations for more than 25 years, with continuous National Institutes of Health funding as a principal investigator on grants since 2001. Gonzales has published her research in top journals in her field.  

Her research on mental health and substance use problems has focused on culturally informed etiological pathways for Latino and other minority adolescents and young adults, including identification of health-compromising and health-promoting influences in the lives of the youths. Her work has particularly focused on the role of family and cultural strengths within immigrant and other minoritized populations that facilitate positive adaptation and educational success. Her research also includes development, implementation and dissemination of culturally informed interventions to prevent mental health and substance abuse problems and to promote college degree attainment in low-income communities.

Gonzales’ research is housed with the REACH Institute at ASU, a center of excellence that is dedicated to the dissemination of evidence-based prevention programs and practices. Funded by several federal agencies and foundations, the center has generated more than $88 million in the past 20 years to support research and implementation of programs nationally and internationally.

As dean of natural sciences, Gonzales oversees six interdisciplinary schools and departments at ASU: the School of Earth and Space Exploration, School of Life Sciences, School of Molecular Sciences, School of Mathematical and Statistical Sciences, the Department of Psychology, and the Department of Physics. In this role she has been particularly dedicated to the pursuit of inclusive excellence in the sciences.  

In addition to her leadership at ASU, Gonzales has consulted with several organizations on issues of equity and inclusion, including the National Academy of Sciences Committee on Developing Indicators of Educational Equity; the National Institute of Mental Health; the National Association of Latino Elected Officials; and as a member of the board of trustees for the William T. Grant Foundation. She also serves on numerous professional boards, review panels and mentoring programs to advance the careers of students and early career faculty in the sciences. Gonzales has received numerous honors and awards including Fellow status in the American Psychological Association, the Advances in Culture and Diversity in Prevention Science Award from the Society for Prevention Research, the Eugene Garcia Award for Outstanding Latino/a Faculty Research in Higher Education from the Victoria Foundation, and the ASU Alumni Association Founders Day Faculty Research Achievement Award (watch her story below). 

Video by ASU

Top photo: Nancy Gonzales, pictured at the Tempe Center for the Arts. Photo by Charlie Leight/ASU

image title

Cold storage is crucial to COVID-19 vaccine distribution

December 1, 2020

Editor’s note: This story is being highlighted in ASU Now’s year in review. Read more top stories from 2020.

Recent news about the coronavirus pandemic has been both harrowing and hopeful. Infections in the United States now exceed 13 million, and more than 3 million of those cases have emerged within just the past three weeks.

Amidst this surge, the results of large clinical trials by the pharmaceutical companies Pfizer and Moderna show their new vaccines are 94% effective or higher. Consequently, both corporations are seeking emergency-use authorization from the Food and Drug Administration to start vaccinations within weeks.

Moderna reports it can have 20 million vaccine doses ready by the end of 2020, and Pfizer says it can have 50 million doses by then. Vaccination with either product requires two injections, so their combined output could mean protection for 35 million people by the end of the year.

A third vaccine has been developed by AstraZeneca, but additional trials are required to verify its efficacy. Most early results indicate 62% effectiveness, but half-size doses on initial injections may yield results as high as 90%.

These breakthroughs are very welcome in a year defined by the heavy toll of the COVID-19 pandemic. But supplying these vaccines requires a feat of logistical precision known as a “cold chain.” All three solutions must be stored at low temperatures: 40 degrees Fahrenheit for the AstraZeneca product, minus 4 degrees Fahrenheit for the Moderna product and minus 94 degrees Fahrenheit for the Pfizer product. Exposure to warmer conditions, such as in transit from production facilities to storage sites, could compromise their potency and undermine the battle against the coronavirus.

Kristen Parrish, an associate professor in the School of Sustainable Engineering and the Built Environment at Arizona State University’s Ira A. Fulton Schools of Engineering, researches the integration of energy efficiency into building design and operational processes. Her recent work includes innovating the cooling technology used in commercial freezer facilities by incorporating phase-change materials. ASU Now spoke with Parrish about aspects of successfully handling these precious new vaccines.

kristen parrish

Kristen Parrish

Question: How is vaccine deployment going to happen?

Answer: Officials are trying to figure that out right now. I have a friend who is working with the Scottsdale Fire Department to determine how to set up a large vaccination center with drive-thru pop-up tents to administer injections. Keeping vaccines in fewer locations with higher-performing, temperature-controlled equipment could better ensure the necessary cold storage conditions. This is especially the case with the Pfizer product, which is likely to be the first vaccine authorized for use. Distribution will demand lots of dry ice and ultra-cold freezer units.

Q: Will it be easier to handle vaccines that don’t require such low temperatures?

A: Yes. Many commercial freezers can operate down to minus 5 degrees Fahrenheit, which works for the Moderna product. And the AstraZeneca vaccine can be stored at temperatures operated by conventional refrigerators. But it’s still a good idea to install separate digital temperature-logging devices among the vaccine doses to verify storage conditions.

Q: All of this refrigeration suggests a lot of energy consumption. Is there some way to soften the blow?

A: Yes, this effort will represent a lot of energy use. But using a phase-change material can help on that front. These are salt hydrates in sheets of units that look like ketchup packets. When heat seeps into a freezer, for example, these passive materials absorb that heat and keep temperatures lower for longer. They don’t help you get to the low temperature you need, but they can help you stay there with less energy demand.

Q: Do these phase-change materials expand our options for vaccination locations?

A: They do. I think of centralized locations using the Pfizer product, along with all of that dry ice and those ultra-cold freezers, to vaccinate health care staff and emergency responders. By contrast, getting assisted living and nursing home residents to central sites is complicated. It could be easier to send health care professionals to them — taking the Moderna or AstraZeneca vaccine doses in coolers that use phase-change materials to maintain required temperatures for several hours. This could also work for transporting vaccines to rural locations.

Q: What about technicians?  Do we have people to support the required technology?

A: That could be a significant issue. We have a finite number of people trained in maintaining and repairing ultra-cold storage equipment. As part of distribution planning, facilities need to make sure they have access to people with the skills to work with these sorts of systems. The number of freezers in service and the number of maintenance calls could double very rapidly.

Q: How can universities play a role in this campaign?

A: One significant role is encouraging people to get vaccinated. ASU represents a lot of nonpartisan experts who can combat the misinformation that seems to happen around vaccines. So, our greatest service may be prompting the people of Arizona and the nation as a whole to show up and get vaccinated. Toward that end, I think about the influence of our enormous student population. If our student leaders can help share the truth about vaccination, I think that could be huge.

Q: Are you hopeful for the potential of these new vaccines?

A: I am. My family and I contracted COVID-19 during the summer. But we were lucky; we had clinically mild cases. We never had to be hospitalized, and we have all since recovered. Of course, that’s not the case for a lot of people. So, distributing and administering effective vaccines offers the promise to save countless lives.

Top photo: New vaccines developed to counter the coronavirus require storage at low temperatures. Distribution demands carefully monitored use of refrigeration technology and specialized logistics known as a "cold chain." Photo courtesy of Shutterstock

Gary Werner

Senior Media Relations Officer , Media Relations and Strategic Communications